Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Research shows the compound influences adipocyte biology with significant changes in fat cell characteristics in experimental models
Vitamin B12 injections deliver 100% bioavailable cobalamin directly into the bloodstream bypassing the stomach acids that destroy oral supplements
What is Vitamin B12 and Why Does It Matter
All applications require individual assessment BPC-157 is not a one-size-fits-all treatment
This solution is Research Use Only (RUO), not intended for medical use and is not approved for diagnostic or therapeutic applications or in neonates